Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.03 (-2.19%)
Close on Nov 18, 2026Market cap $4.89MP/E –Yield –
Pulmatrix revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pulmatrix's revenue for the twelve months ending Dec 31, 2024 was $7.81M, up 7.0% year over year. For fiscal 2024 it was $7.81M, up 7.0% from the year before. Over ten years it grew 36.3% a year on average. The highest annual figure on record is $12.63M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.81M | +7.0% |
| FY2023 | Dec 31, 2023 | $7.30M | +20.2% |
| FY2022 | Dec 31, 2022 | $6.07M | +17.5% |
| FY2021 | Dec 31, 2021 | $5.17M | -59.1% |
| FY2020 | Dec 31, 2020 | $12.63M | +59.7% |
| FY2019 | Dec 31, 2019 | $7.91M | +5069.9% |
| FY2018 | Dec 31, 2018 | $153.00K | -54.3% |
| FY2017 | Dec 31, 2017 | $335.00K | -59.9% |
| FY2016 | Dec 31, 2016 | $835.00K | -30.5% |
| FY2015 | Dec 31, 2015 | $1.20M | +241.2% |
| FY2014 | Dec 31, 2014 | $352.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $3.00K | -99.9% |
| Q3 FY2024 | Sep 30, 2024 | $366.00K | -79.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.55M | -15.8% |
| Q1 FY2024 | Mar 31, 2024 | $5.89M | +292.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.20M | +28.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.75M | -6.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.84M | +38.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.50M | +29.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.71M | +274.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.87M | +75.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.33M | -40.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.16M | -16.5% |
| Q4 FY2021 | Dec 31, 2021 | $456.00K | -77.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.07M | -75.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.25M | -35.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.39M | -49.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.00M | +18.7% |
| Q3 FY2020 | Sep 30, 2020 | $4.37M | +211.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.50M | -27.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.76M | +1705.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.69M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.41M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.82M | +3049.7% |
| Q4 FY2018 | Dec 31, 2018 | $153.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $153.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $335.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $117.00K | – |
See a number that looks wrong?